Corvus Pharmaceuticals | 10-Q: Quarterly report

Futu NewsMay 8 05:22 · Announcements

Corvus Pharmaceuticals Insider Bought Shares Worth $1,000,000, According to a Recent SEC Filing

Richard A Miller, Director, President and CEO, on May 06, 2024, executed a purchase for 577,634 shares in Corvus Pharmaceuticals (CRVS) for $1,000,000. Following the Form 4 filing with the SEC, Miller

MT NewswiresMay 8 05:12

Corvus Pharmaceuticals Shares Are Trading Lower After the Company Reported Q1 Financial Results.

Corvus Pharmaceuticals Shares Are Trading Lower After the Company Reported Q1 Financial Results.

BenzingaMay 8 00:30

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 7 23:07

NanoViricides, TC BioPharm, Holdco Nuvo Among Healthcare Movers

Seeking AlphaMay 7 22:01

Corvus Pharmaceuticals Is Maintained at Outperform by Oppenheimer

Corvus Pharmaceuticals Is Maintained at Outperform by Oppenheimer

Dow JonesMay 7 20:15